Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients With Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
The purpose of this trial is to study how well pemetrexed disodium or observation works in treating patients with malignant pleural mesothelioma without progressive disease after first-line chemotherapy. Pemetrexed disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Stanford is now accepting new patients for this trial.
- drug : pemetrexed disodium
- other : clinical observation
Phase: Phase 2
Ages Eligible For Study: